2 posts / 0 new
Last post
#1 Thu, 05/10/2018 - 16:12
Paula Fernandes

Ebola Outbreak DRC - Diagnostics and Vaccines

I'm assuming Xpert is being used for diagnosis in current outbreak given their capacity: http://www.who.int/emergencies/ebola-DRC-2017/articles/rapid-diagnosis/en/ 

My main concerns are that they 1. have good diagnostics at the source of cases and 2. maximize opportunities to use the new vaccine. I haven't seen any vaccination roll-out plans, have you?

http://www.who.int/news-room/detail/08-05-2018-new-ebola-outbreak-declared-in-democratic-republic-of-the-congo

Mon, 05/14/2018 - 16:22
Tiffany Tsang

Reply:

Hi Paula,

Thank you for posting a comment! I've looked through reports and only coming up with news articles relating to the use of the Merck rVSV-ZEBOV vaccine and early reports suggests the vaccine is safe and effective.

The news article that cites this: https://www.washingtonpost.com/news/to-your-health/wp/2018/05/14/ebola-has-infected-dozens-so-far-in-congo-killing-19-who-says/?utm_term=.5c37a8998db9

You bring up a good question about the diagnostic capabilities at the source cases. I'm also curious if they are able to process the sampling and analysis in country or are they shipping it out to a regional or national reference lab? Obviously, timing is essential in these outbreaks so being able to perform diagnostics close to the incidence of disease would assist in rapid therapeutic and vaccine deployments.

I would love it if the community can chime in with other pieces of information as they come across it.

Thank you!

Tiffany

Log in to post comments